The endothelium plays a crucial role in the control of vascular homoeostasis through maintaining the synthesis of the vasoprotective molecule NO• (nitric oxide). Endothelial dysfunction of cerebral blood vessels, manifested as diminished NO• bioavailability, is a common feature of several vascular-related diseases, including hypertension, hypercholesterolaemia, stroke, subarachnoid haemorrhage and Alzheimer's disease. Over the past several years an enormous amount of research has been devoted to understanding the mechanisms underlying endothelial dysfunction. As such, it has become apparent that, although the diseases associated with impaired NO• function are diverse, the underlying causes are similar. For example, compelling evidence indicates that oxidative stress might be an important mechanism of diminished NO• signalling in diverse models of cardiovascular ‘high-risk’ states and cerebrovascular disease. Although there are several sources of vascular ROS (reactive oxygen species), the enzyme NADPH oxidase is emerging as a strong candidate for the excessive ROS production that is thought to lead to vascular oxidative stress. The purpose of the present review is to outline some of the mechanisms thought to contribute to endothelial dysfunction in the cerebral vasculature during disease. More specifically, we will highlight current evidence for the involvement of ROS, inflammation, the RhoA/Rho-kinase pathway and amyloid β-peptides. In addition, we will discuss currently available therapies for improving endothelial function and highlight future therapeutic strategies.
Skip Nav Destination
Article navigation
Review Article|
April 07 2010
Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention
Alyson A. Miller;
Alyson A. Miller
1Department of Pharmacology, Monash University, Clayton, Victoria 3800, Australia
Search for other works by this author on:
Klaudia Budzyn;
Klaudia Budzyn
1Department of Pharmacology, Monash University, Clayton, Victoria 3800, Australia
Search for other works by this author on:
Christopher G. Sobey
1Department of Pharmacology, Monash University, Clayton, Victoria 3800, Australia
Correspondence: Dr Christopher G. Sobey (email [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
December 14 2009
Revision Received:
February 02 2010
Accepted:
February 25 2010
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© The Authors Journal compilation © 2010 Biochemical Society
2010
Clin Sci (Lond) (2010) 119 (1): 1–17.
Article history
Received:
December 14 2009
Revision Received:
February 02 2010
Accepted:
February 25 2010
Citation
Alyson A. Miller, Klaudia Budzyn, Christopher G. Sobey; Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention. Clin Sci (Lond) 1 July 2010; 119 (1): 1–17. doi: https://doi.org/10.1042/CS20090649
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |